Cart
sales@molnova.com
VX-11e
CAS No. 896720-20-0
VX-11e( VX 11e )
Catalog No. M16451 CAS No. 896720-20-0
A potent, selective, and orally bioavailable inhibitor of ERK2 with Ki of <2 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 2MG | 48 | In Stock |
|
| 5MG | 86 | In Stock |
|
| 10MG | 118 | In Stock |
|
| 25MG | 226 | In Stock |
|
| 50MG | 352 | In Stock |
|
| 100MG | 544 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVX-11e
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, and orally bioavailable inhibitor of ERK2 with Ki of <2 nM.
-
DescriptionA potent, selective, and orally bioavailable inhibitor of ERK2 with Ki of <2 nM; shows >200-fold selectivity over GSK3, Aurora A, CDK2, FLT3, etc; significantly inhibits CKAP2 overexpression-induced cell proliferation, migration and invasion in SiHa cells.
-
In Vitro——
-
In Vivo——
-
SynonymsVX 11e
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorAuroraA|CDK2|ERK2|FLT3|GSK-3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number896720-20-0
-
Formula Weight500.3523
-
Molecular FormulaC24H20Cl2FN5O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(C1=CC(C2=NC(NC3=CC=C(F)C=C3Cl)=NC=C2C)=CN1)N[C@@H](C4=CC=CC(Cl)=C4)CO
-
Chemical Name1H-Pyrrole-2-carboxamide, 4-[2-[(2-chloro-4-fluorophenyl)amino]-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Aronov AM, et al. J Med Chem. 2009 Oct 22;52(20):6362-8.
2. Krepler C, et al. Clin Cancer Res. 2016 Apr 1;22(7):1592-602.
3. Guo QS, et al. Sci Rep. 2017 May 18;7(1):2117.
molnova catalog
related products
-
1-Butanol
1-Butanol has an antioxidant effect, can decrease hyperglycemia. 1-Butanol has anti-allergic inflammatory effects by inhibiting the degranulation of mast cells and the expression of inflammatory cytokines.
-
NVP 231
NVP-231 is a potent, specific, and reversible CerK inhibitor(IC50=12±2 nM) that competitively inhibits binding of ceramide to CerK.
-
Asperulosidic acid
Asperulosidic acid has anti-tumor, anti-oxidant, and anti-inflammatory activities.ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways.
